Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound.
In staphylococci, quorum sensing regulates both biofilm formation and toxin production, moreover it has been demonstrated to be inhibited by RNAIII inhibiting peptide (RIP). Aim our study was to evaluate the in vitro activity and its in vivo efficacy of the combined administration of FS10, a novel R...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4890846?pdf=render |
_version_ | 1828390660017750016 |
---|---|
author | Oriana Simonetti Oscar Cirioni Ivana Cacciatore Leonardo Baldassarre Fiorenza Orlando Elisa Pierpaoli Guendalina Lucarini Elena Orsetti Mauro Provinciali Erika Fornasari Antonio Di Stefano Andrea Giacometti Annamaria Offidani |
author_facet | Oriana Simonetti Oscar Cirioni Ivana Cacciatore Leonardo Baldassarre Fiorenza Orlando Elisa Pierpaoli Guendalina Lucarini Elena Orsetti Mauro Provinciali Erika Fornasari Antonio Di Stefano Andrea Giacometti Annamaria Offidani |
author_sort | Oriana Simonetti |
collection | DOAJ |
description | In staphylococci, quorum sensing regulates both biofilm formation and toxin production, moreover it has been demonstrated to be inhibited by RNAIII inhibiting peptide (RIP). Aim our study was to evaluate the in vitro activity and its in vivo efficacy of the combined administration of FS10, a novel RIP derivative, and tigecycline in an animal model of methicillin-resistant (MR) and methicillin-sensitive (MS) Staphylococcus aureus wound infection. Using a 1.x2 cm template, one full thickness wound was established through the panniculus carnosus on the back subcutaneous tissue of each animal. Infection was determined by inoculation of 5x107 CFU/ml of bacteria, that produced an abscess within 24 h, after this, treatment was initiated. The study included, for each strain, a control group without infection, a control infected group that did not receive any treatment and a control infected group with drug-free foam dressing, and three infected groups treated, respectively, with: FS10-soaked foam dressing (containing 20 μg FS10), daily intraperitoneal tigecycline (7 mg/Kg), FS10-soaked foam dressing (containing 20 μg FS10) and daily intraperitoneal injections of tigecycline (7 mg/Kg). The main outcome measures were quantitative culture and histological examination of tissue repair. The highest inhibition of infection was achieved in the group that received FS10-soaked and parenteral tigecycline reducing the bacterial load from 107 CFU/ml to about 103 CFU/g for MSSA and to about 104 CFU/g for MRSA. The group treated with FS10-soaked foam dressing associated with parenteral tigecycline showed, histologically, better overall healing with epithelialization and collagen scores significantly higher than those of the other groups in both strains. In conclusion, the combined use of topical FS10 with i.p. tigecycline induced positive interaction in vivo, resulting in an enhanced therapeutic benefit versus staphylococcal infections in murine wound models. |
first_indexed | 2024-12-10T06:48:25Z |
format | Article |
id | doaj.art-1e102437b55c4c7a82f99ff11eb6bd60 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T06:48:25Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-1e102437b55c4c7a82f99ff11eb6bd602022-12-22T01:58:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015195610.1371/journal.pone.0151956Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound.Oriana SimonettiOscar CirioniIvana CacciatoreLeonardo BaldassarreFiorenza OrlandoElisa PierpaoliGuendalina LucariniElena OrsettiMauro ProvincialiErika FornasariAntonio Di StefanoAndrea GiacomettiAnnamaria OffidaniIn staphylococci, quorum sensing regulates both biofilm formation and toxin production, moreover it has been demonstrated to be inhibited by RNAIII inhibiting peptide (RIP). Aim our study was to evaluate the in vitro activity and its in vivo efficacy of the combined administration of FS10, a novel RIP derivative, and tigecycline in an animal model of methicillin-resistant (MR) and methicillin-sensitive (MS) Staphylococcus aureus wound infection. Using a 1.x2 cm template, one full thickness wound was established through the panniculus carnosus on the back subcutaneous tissue of each animal. Infection was determined by inoculation of 5x107 CFU/ml of bacteria, that produced an abscess within 24 h, after this, treatment was initiated. The study included, for each strain, a control group without infection, a control infected group that did not receive any treatment and a control infected group with drug-free foam dressing, and three infected groups treated, respectively, with: FS10-soaked foam dressing (containing 20 μg FS10), daily intraperitoneal tigecycline (7 mg/Kg), FS10-soaked foam dressing (containing 20 μg FS10) and daily intraperitoneal injections of tigecycline (7 mg/Kg). The main outcome measures were quantitative culture and histological examination of tissue repair. The highest inhibition of infection was achieved in the group that received FS10-soaked and parenteral tigecycline reducing the bacterial load from 107 CFU/ml to about 103 CFU/g for MSSA and to about 104 CFU/g for MRSA. The group treated with FS10-soaked foam dressing associated with parenteral tigecycline showed, histologically, better overall healing with epithelialization and collagen scores significantly higher than those of the other groups in both strains. In conclusion, the combined use of topical FS10 with i.p. tigecycline induced positive interaction in vivo, resulting in an enhanced therapeutic benefit versus staphylococcal infections in murine wound models.http://europepmc.org/articles/PMC4890846?pdf=render |
spellingShingle | Oriana Simonetti Oscar Cirioni Ivana Cacciatore Leonardo Baldassarre Fiorenza Orlando Elisa Pierpaoli Guendalina Lucarini Elena Orsetti Mauro Provinciali Erika Fornasari Antonio Di Stefano Andrea Giacometti Annamaria Offidani Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. PLoS ONE |
title | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. |
title_full | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. |
title_fullStr | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. |
title_full_unstemmed | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. |
title_short | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound. |
title_sort | efficacy of the quorum sensing inhibitor fs10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound |
url | http://europepmc.org/articles/PMC4890846?pdf=render |
work_keys_str_mv | AT orianasimonetti efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT oscarcirioni efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT ivanacacciatore efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT leonardobaldassarre efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT fiorenzaorlando efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT elisapierpaoli efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT guendalinalucarini efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT elenaorsetti efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT mauroprovinciali efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT erikafornasari efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT antoniodistefano efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT andreagiacometti efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound AT annamariaoffidani efficacyofthequorumsensinginhibitorfs10aloneandincombinationwithtigecyclineinananimalmodelofstaphylococcalinfectedwound |